Quest Diagnostics (DGX) Total Current Liabilities (2009 - 2026)

Quest Diagnostics has disclosed Total Current Liabilities across 18 years of filings, most recently posting $1.8 billion for Q2 2026.

• In Q2 2026, Total Current Liabilities fell 11.66% year-over-year to $1.8 billion; the TTM figure through Jun 2026 stood at $1.8 billion (down 11.66% YoY), while the FY2025 annual figure was $2.3 billion, up 5.03% from the prior year.
• Total Current Liabilities came in at $1.8 billion for Q2 2026 at Quest Diagnostics, down from $2.2 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.3 billion in Q1 2024 to a low of $1.4 billion in Q1 2023.
• Average Total Current Liabilities over 5 years is $1.9 billion, with a median of $1.8 billion recorded in 2023.
• Year-over-year, Total Current Liabilities soared 69.59% in 2024 and sank 37.29% in 2025.
• Over 5 years, Total Current Liabilities stood at $1.6 billion in 2022, then grew by 17.02% to $1.8 billion in 2023, then rose by 19.5% to $2.2 billion in 2024, then increased by 5.03% to $2.3 billion in 2025, then slipped by 21.51% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $1.8 billion in Q2 2026, $2.2 billion in Q1 2026, and $2.3 billion in Q4 2025.